Inflammation’s Role In Neurological Disease Part 2: INmune Bio (NASDAQ:INMB)

Human brain - top view blue 3d render isolated on white

Jezperklauzen/iStock via Getty Images

A few weeks ago, I wrote about Coya Therapeutics (COYA) and their approach to neuroinflammatory disease. Part 2 of my neuroinflammation series will examine a company called INmune Bio (NASDAQ:INMB) which

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *